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ABSTRACT
Using the vasoconstrictive effects of topical steroid application as a marker, we
studied the effect of anhidrosis on the percutaneous absorption of a corticosteroid
ointment and cream. We found that a decrease in sweating ability resulted in a de-
crease in blanching and presumably in percutaneous absorption of steroid.
Occluding the skin augments percutaneous
absorption of the cortiocosteroids and other
substances by increasing epidermal hydration
and temperature (1, 2). McKenzie and
Stoughton (3) have demonstrated that after
applying a corticosteroid to the skin and oc-
cluding the treated area with polyethylene
film there results an area of vasoconstriction
which may be used as an indicator of steroid
absorption.
Although increased hydration increases per-
cutaneous absorption, little information is
available concerning the effect of anhidrosis
(decreased hydration) on percutaneous absorp-
tion. Since there are patients who have re-
duced sweating ability and who may have need
of topical corticosteroid therapy, it would be of
interest to study the effect of complete or rela-
tive anhidrosis on the vasoconstriction caused
by corticosteroids. We studied subjects who
were hypohidrotic secondary to disease, as well
as those made hypohidrotic by topical chemical
means.
MATERIALS AND METHODS
Subjects. Forty-two male and ten female volun-
teers ranging in age from ten to sixty-four years
were studied. There were forty-six caucasians and
six negroes. Thirty-one patients had spinal cord
and varying degrees of sympathetic nervous sys-
tem injury resulting from trauma or systemic dis-
eases; four patients had had either dorsal or
lumbar sympathectomies, and one patient had
congenital anhidrotic ectodermal dysplasia. Six-
teen subjects were normal, healthy volunteers.
Disease induced hypohidrosi.s. In each of thirty-
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five patients (those with cord and/or sympathetic
injury) and one patient with anhidrotic ectodermal
dysplasia, sweating was evaluated in at least two
cutaneous areas. The areas chosen were: on a limb
below the level of spinal cord injury or on the
side of the sympathectomy; and on a limb in an
area believed to be unaffected by cord injury or
sympathectomy, In the patient with anhidrotic
ectodermal dysplasia areas on the arm and the
leg were studied. Sweating was evaluated before
and after occlusion with polyethylene film for
twenty-four hours by the application of O-phthal-
aldehyde to the skin, after the method of Juhlin
and Shelley (4). (These authors have shown that
5% O-phthalaldehyde in xylene painted on the
skin will stain sweat pores and stratum corneum
black in normally sweating areas, but will noI
stain anhidrotic sites.) We considered those sites
which had no or minimal staining with O-phthal-
aldehyde as having decreased sweating, and we will
refer to these patients as "anhidrotic."
The sweat-evaluated sites were then tested for
vasoconstriction in the following manner: 250 mg
of (0.025%) fluocinolone acetonidet ointment and
cream was applied, and the skin occluded with
polyethylene film for twenty-four hours, accord-
ing to the method of McKenzie and Stoughton
(3). Normally sweating sites in these patients were
used as controls. Blanching vasoconstriction in
normal areas was compared to that produced in
the anhidrotic sites.
If an area of anhidrosis was found to show no
blanching, the procedure was repeated, using a one-
inch square gauze sponge saturated with 4 cc
physiological saline sandwiched between the ster-
oid preparation and the polyethylene film and
again compared to a control site.
Other pharmacologic studies. Sweating response
to acetylcholine was studied in the patient with
anhidrotic ectodermal dysplasia and in those pa-
tients (8) with decreased or absent sweating. In
each subject two areas were injected intradermally
with 0.1 cc of 1:1000 acetylcholine aqueous solu-
tion. The injected areas were then treated with
a drop of O-phthalaldehyde in order to test for
sweat staining.
All patients who showed no blanching response
to steroids were injected intradermallv with nor-
epinephrine (0.1 cc of the bitartrate 0.2% in water)
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Chemically induced hypohidrosis. Sixteen nor-
mal, healthy subjects were identically studied. The
forearms were carefully cleaned with 700 ethyl
alcohol and allowed to dry. The ventral surface of
one forearm was treated with a thin coat (ap-
proximately 0.1 cc) of an antiperspirant (con-
sisting of p-methoxybenzoylscopolamine HBr 0.1%,
ethanol 25% in distilled water adjusted to pH 3
with HC1).* The other arm was left untreated.
After a few minutes, both forearms had 250 mg
(0.025%) fluocinolone acetonide cream and poly-
ethylene wrap applied to them in a manner identi-
cal to that described above. After five to six hours,
blanching response was compared in both fore-
arms.
RESULTS
Sweating. The patient with anhidrotic ecto-
dermal dysplasia had no sweating or sweat
glands, as evidenced by the lack of O-phthal-
aldehyde staining and histological examination
of the skin.
Of the patients with spinal cord injury,
twenty-two (44 sites) showed normal sweating
above and below the area of cord injury and
were considered to have some sympathetic
nervous system activity intact. These patients
served as controls. In the remaining thirteen
patients, eight sites showed decreased and eight
showed absent sweating in the sympathecto-
mized areas as compared to ten normal skin
sites.
Under our experimental conditions, none of
the normal individuals studied were found to be
anhidrotic seven hours after occlusion with the
scopolamine ester and occlusive wrap. After
five to six hours of such an occlusive dressing,
six of the sixteen normal subjects were still
anhidrotic (little or no staining with O-phthal-
aldehyde on the antiperspirant treated fore-
arm). The remaining ten subjects showed
staining and no anhidrotic effect after five to
six hours in the treated areas. No systemic
symptoms or topical side effects were noted.
Vasocon.striction. Subtle differences in
blanching are difficult to assess, and we made
no attempt to do so. When there was an
equivocal difference in blanching between two
areas, this difference was ignored. For a differ-
ence in blanching to be considered significant
there had to be a distinct difference between
*Kindly supplied by the Procter and Gamble
Company, Cincinnati, Ohio.
the experimental site and the control site, as
seen by at least two observers.
When the sixteen sweat deficient sites from
the patients who had a sympathetic nerve
deficit, as well as the two sites from the patient
with ectodermal dysplasia with decreased.
sweating, were treated with a steroid ointment
or cream and occluded for twenty-four hours
we found decreased or absent blanching in
seventeen of them.
When the seventeen sites resistant to steroid
blanching were retreated with fluocinolone ace—
tonide cream and normal physiological saline,
as well as the polyethylene film, thirteen
showed blanching, but four remained resistant.
Steroid cream (containing some water) was
more effective in producing blanching in an-
hidrotic skin then steroid ointment, which was
ineffective.
Normal subjects. In those six subjects who
showed hypo or anhidrosis on the antiperspir-
ant treated area, there was little or no blanch—
ing response seen, as compared to the control
area (see Figure 1). There was blanching seen
in the antiperspirant treated area in the ten
subjects, in whom the antiperspirant used was
found to be ineffective.
Other pharmacologic studies. Acetylcholine
injected intradermally did not cause sweating
in the subject with anhidrotie ectodermal dys—
plasia (2 sites) or in six of the sixteen cord
injured subjects (12 sites). The remaining ten
cord injured subjects did show a sweating re-
sponse to acetylcholine; suggesting that, al-
though their sweat apparatus did not functiom
under normal circumstances, it could respond
to pharmacologic stimulation.
All subjects tested showed a vasoconstrictive
response to intracutaneous norepinephrine.
DISCUSSION
In order to study the effect of anhidrosis on
percutaneous absorption of a corticosteroid, we
tried to produce vasoeonstrictive blanching in
arihidrotic skin by applying to it a steroid
preparation under occlusion.
We found that among thirty-five patients
(72 sites) with cord injury, twenty-two sub-jects (44 sites) were able to sweat equally
above and below the site of injury and gave
normal vasoconstrictive responses to a steroid
in these areas. Thirteen patients showed nor—
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FIG. 1. Vasoconstrictive response to topical fluocinolone cream after occlusion is seen in
the normally sweating right arm. The similarly treated left arm, which previously had been
made anhidrotic, does not show the same constrictive response. The dark spot on the right
arm represents a stain produced by o-pthalaldehyde.
ma! sweating above (10 sites) and decreased
sweating below (16 sites) an area of cord and/
or sympathetic nerve injury. One patient with
anhidrotic ectodermal dysplasia also showed no
sweating in two sites. Of these eighteen anhi-
drotic sites, seventeen showed reduced or ab-
sent vasoconstruction on application of a ster-
oid cream or ointment under occlusive dressing.
When hydration was provided in the form of
physiological saline, and the steroid prepara-
tion was then added to these seventeen sites,
we were able to demonstrate vasoconstrietion
in thirteen of them. Four sites remained re-
sistant to steroid vasoconstrietion, even in the
presence of water and occlusion.
With the use of a topical antiperspirant, p-
methoxybenzoylscopolamine hydrobromide pre-
viously studied by MacMillan, Reller and
Snyder (5), we were able to induce relative
anhidrosis in six of the sixteen patients for a
period of up to six hours. This was a period
long enough to attempt the production of
vasoconstriction with topical application of
steroid cream. The application of steroid for
shorter periods, in trial runs, was not effective
in producing blanching and, for longer periods,
no effective anhidrosis could be achieved. Even
in the five to six hour period, only six of the
sixteen patients could be made anhidrotic but,
where this was achieved, no blanching was
seen—suggesting that chemically induced anhi-
drosis decreased, as well, the amount of steroid
vasoconstriction which could be achieved.
Previous studies have shown that increasing
the hydration of the stratum corneum increases
the percutaneous absorption of corticosteroids
(1, 2, 3), and it seems reasonable to conclude
from our study that a decrease in hydration
results in some inhibition of percutaneous ab-
sorption. Transepidermal water loss appears to
be inadequate to make up the sweat deficit. If
vasoconstrietion is an indication of therapeutic
efficacy, then anhidrotic patients appear to
have a defect which probably results in their
absorbing inadequate amounts of steroids to
produce that vasoconstriction. This latter find-
ing may have important implications when
topical corticosteroid therapy is contemplated
in patients with hypo- or anhidrosis.
The authors wish to thank Miss Kathy Joseph
for her invaluable assistance.
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